CTLA4 and neoplasm: Although CTLA-4 is highly expressed in Tregs and serves a crucial role in conventional T cell self-tolerance, CTLA-4 blockade combined with Treg depletion strategies has demonstrated significant therapeutic efficacy in tumor treatment and autoimmune disease management [63].